Market Overview:
The global orthopedics joint cavity viscoelastic supplement market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of deformable knee joint diseases, periarthritis of shoulder, and other applications. In addition, the growing awareness about the benefits of using orthopedics joint cavity viscoelastic supplements is also contributing to the growth of this market. Based on type, the global orthopedics joint cavity viscoelastic supplement market can be segmented into 2ml, 2.5ml, and 3ml segments. The 2ml segment is expected to account for a major share in terms of revenue in 2018 owing to its high usage rates across various applications such as deformable knee joint disease and periarthritis of shoulder.
Product Definition:
Orthopedics Joint Cavity Viscoelastic Supplement is a medical device that is used to help improve the function of joints. It can be used to help reduce pain and inflammation, and may also help to improve joint movement.
2ml:
2ml is a small size container that holds around 2 ml of viscosupplement. It's primary function is to be added in the joint cavity along with the other orthopedic supplements during surgery. The other functions of this little bottle are to keep the surgical field clean and also provide an entry point for drugs or fluids by giving a negative pressure inside it.
2.5ml:
2.5ml is the standard size of orthopedic joint cavity viscoelastic supplement used in the treatment of articular cartilage defects and osteoarthritis. It is also used to lubricate damaged joints, reduce pain & swelling, and help with range of motion restoration post-injury or surgery.
Application Insights:
The deformable knee joint disease segment dominated the global orthopedics joint cavity viscosupplement market in terms of revenue share in 2017. The growing prevalence of osteoarthritis is one of the major factors driving this segment. According to a study published by the Arthritis Foundation, around 54 million people aged over 18 years have arthritis or rheumatic conditions worldwide. In Europe, around 24 million people are affected by arthritis and it is projected that by 2050, this number will reach about 56 million across all age groups.
Infectious diseases accounted for a significant share in 2017 owing to rising incidences of hospital-acquired infections and rising geriatric population prone to infectious diseases like tuberculosis (TB).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments by key players, rising geriatric population, and high prevalence of osteoarthritis and other joint diseases such as rheumatoid arthritis (RA) & osteoporosis in this region. In addition, favorable reimbursement policies for orthopedic procedures are also propelling growth of this regional market.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare infrastructure coupled with growing medical tourism industry in emerging countries such as India and China owing to low costs associated with various treatments compared to developed regions including U.S.
Growth Factors:
- Increasing incidence of joint pain and arthritis: The increasing incidence of joint pain and arthritis is one of the key growth drivers for the orthopedics joint cavity viscoelastic supplement market. According to a study by the Centers for Disease Control and Prevention (CDC), approximately 54 million adults in the U.S. suffer from some form of arthritis, which is a major contributor to disability in America. This number is expected to increase significantly in the next few years due to rising obesity rates and an aging population. This will create significant demand for orthopedics joint cavity viscoelastic supplements, thereby driving market growth.
- Growing awareness about benefits of orthopedics joint cavity viscoelastic supplements: There is growing awareness among people about the benefits of using orthopedics joint cavity viscoelastic supplements, which is another key driver for this market segment. People are increasingly becoming aware that these supplements can help improve mobility and reduce pain associated with various types of arthritis, thereby leading to increased demand for these products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Orthopedics Joint Cavity Viscoelastic Supplement Market Research Report
By Type
2ml, 2.5ml, 3ml
By Application
Deformable Knee Joint Disease, Periarthritis of Shoulder, Other
By Companies
Haohai Biological, Japan Biochemistry, Jingfeng Pharmaceutical, Bausch & Lomb, Ethicon, SANOFI, Baxter International, Pathfinder Cell Therapy, Medtronic, Haohai Biological
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Orthopedics Joint Cavity Viscoelastic Supplement Market Report Segments:
The global Orthopedics Joint Cavity Viscoelastic Supplement market is segmented on the basis of:
Types
2ml, 2.5ml, 3ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Deformable Knee Joint Disease, Periarthritis of Shoulder, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haohai Biological
- Japan Biochemistry
- Jingfeng Pharmaceutical
- Bausch & Lomb
- Ethicon
- SANOFI
- Baxter International
- Pathfinder Cell Therapy
- Medtronic
- Haohai Biological
Highlights of The Orthopedics Joint Cavity Viscoelastic Supplement Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2ml
- 2.5ml
- 3ml
- By Application:
- Deformable Knee Joint Disease
- Periarthritis of Shoulder
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Orthopedics Joint Cavity Viscoelastic Supplement Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Orthopedics Joint Cavity Viscoelastic Supplement is a supplement that is designed to help improve joint cavities and reduce inflammation. It contains ingredients that are thought to help improve the function of the joints, as well as reduce inflammation.
Some of the key players operating in the orthopedics joint cavity viscoelastic supplement market are Haohai Biological, Japan Biochemistry, Jingfeng Pharmaceutical, Bausch & Lomb, Ethicon, SANOFI, Baxter International, Pathfinder Cell Therapy, Medtronic, Haohai Biological.
The orthopedics joint cavity viscoelastic supplement market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Orthopedics Joint Cavity Viscoelastic Supplement Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Orthopedics Joint Cavity Viscoelastic Supplement Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Orthopedics Joint Cavity Viscoelastic Supplement Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Orthopedics Joint Cavity Viscoelastic Supplement Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Orthopedics Joint Cavity Viscoelastic Supplement Market Size & Forecast, 2018-2028
4.5.1 Orthopedics Joint Cavity Viscoelastic Supplement Market Size and Y-o-Y Growth
4.5.2 Orthopedics Joint Cavity Viscoelastic Supplement Market Absolute $ Opportunity
Chapter 5 Global Orthopedics Joint Cavity Viscoelastic Supplement Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Type
5.2.1 2ml
5.2.2 2.5ml
5.2.3 3ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Orthopedics Joint Cavity Viscoelastic Supplement Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Applications
6.2.1 Deformable Knee Joint Disease
6.2.2 Periarthritis of Shoulder
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Orthopedics Joint Cavity Viscoelastic Supplement Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Orthopedics Joint Cavity Viscoelastic Supplement Analysis and Forecast
9.1 Introduction
9.2 North America Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Type
9.6.1 2ml
9.6.2 2.5ml
9.6.3 3ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Applications
9.10.1 Deformable Knee Joint Disease
9.10.2 Periarthritis of Shoulder
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Orthopedics Joint Cavity Viscoelastic Supplement Analysis and Forecast
10.1 Introduction
10.2 Europe Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Type
10.6.1 2ml
10.6.2 2.5ml
10.6.3 3ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Applications
10.10.1 Deformable Knee Joint Disease
10.10.2 Periarthritis of Shoulder
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Orthopedics Joint Cavity Viscoelastic Supplement Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Type
11.6.1 2ml
11.6.2 2.5ml
11.6.3 3ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Applications
11.10.1 Deformable Knee Joint Disease
11.10.2 Periarthritis of Shoulder
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Orthopedics Joint Cavity Viscoelastic Supplement Analysis and Forecast
12.1 Introduction
12.2 Latin America Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Type
12.6.1 2ml
12.6.2 2.5ml
12.6.3 3ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Applications
12.10.1 Deformable Knee Joint Disease
12.10.2 Periarthritis of Shoulder
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Orthopedics Joint Cavity Viscoelastic Supplement Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Type
13.6.1 2ml
13.6.2 2.5ml
13.6.3 3ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Orthopedics Joint Cavity Viscoelastic Supplement Market Size Forecast by Applications
13.10.1 Deformable Knee Joint Disease
13.10.2 Periarthritis of Shoulder
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Orthopedics Joint Cavity Viscoelastic Supplement Market: Competitive Dashboard
14.2 Global Orthopedics Joint Cavity Viscoelastic Supplement Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haohai Biological
14.3.2 Japan Biochemistry
14.3.3 Jingfeng Pharmaceutical
14.3.4 Bausch & Lomb
14.3.5 Ethicon
14.3.6 SANOFI
14.3.7 Baxter International
14.3.8 Pathfinder Cell Therapy
14.3.9 Medtronic
14.3.10 Haohai Biological
